GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioForce Nanosciences Holdings Inc (OTCPK:BFNH) » Definitions » Asset Turnover

BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Asset Turnover : 0.00 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is BioForce Nanosciences Holdings Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. BioForce Nanosciences Holdings's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. BioForce Nanosciences Holdings's Total Assets for the quarter that ended in Dec. 2023 was $0.00 Mil. Therefore, BioForce Nanosciences Holdings's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. BioForce Nanosciences Holdings's annualized ROE % for the quarter that ended in Dec. 2023 was 25.88%. It is also linked to ROA % through Du Pont Formula. BioForce Nanosciences Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was -45,600.00%.


BioForce Nanosciences Holdings Asset Turnover Historical Data

The historical data trend for BioForce Nanosciences Holdings's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioForce Nanosciences Holdings Asset Turnover Chart

BioForce Nanosciences Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 - - - -

BioForce Nanosciences Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioForce Nanosciences Holdings's Asset Turnover

For the Packaged Foods subindustry, BioForce Nanosciences Holdings's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioForce Nanosciences Holdings's Asset Turnover Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's Asset Turnover distribution charts can be found below:

* The bar in red indicates where BioForce Nanosciences Holdings's Asset Turnover falls into.



BioForce Nanosciences Holdings Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

BioForce Nanosciences Holdings's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0/( (0.001+0.001)/ 2 )
=0/0.001
=0.00

BioForce Nanosciences Holdings's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (0.001+0.001)/ 2 )
=0/0.001
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


BioForce Nanosciences Holdings  (OTCPK:BFNH) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

BioForce Nanosciences Holdings's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-0.456/-1.762
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.456 / 0)*(0 / 0.001)*(0.001/ -1.762)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.0006
=ROA %*Equity Multiplier
=-45,600.00 %*-0.0006
=25.88 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

BioForce Nanosciences Holdings's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-0.456/0.001
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.456 / 0)*(0 / 0.001)
=Net Margin %*Asset Turnover
= %*0
=-45,600.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


BioForce Nanosciences Holdings Asset Turnover Related Terms

Thank you for viewing the detailed overview of BioForce Nanosciences Holdings's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Business Description

Traded in Other Exchanges
N/A
Address
2020 General Booth Boulevard, Suite 230, Virginia Beach, VA, USA, 23454
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing.
Executives
Richard Kaiser Kaiser director, 10 percent owner, officer: Secretary/Acting CFO 3419 VIRGINIA BEACH BLVD, UNIT 252, VIRGINIA BEACH VA 23452
Merle Ferguson director, 10 percent owner, officer: CEO/President/Treasurer 2020 GENERAL BOOTH BLVD., SUITE 230, VIRGINIA BEACH VA 23454
Susan Donohue 10 percent owner 19001 S. RICHFIELD AVE, #102, GREEN VALLEY AZ 85614
Michael D Dunham director 12000 W PARK PL, EFFECTIVE MANAGEMENT SYSTEMS INC, MILWAUKEE WI 53224
Gregory D Brown officer: Chief Financial Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010-8098
Kerry M Frey officer: Chief Operating Officer BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010
Eric Henderson director, 10 percent owner BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Lawrence Marshall Gold director 830 MENLO AVENUE, SUITE 100, MENLO PARK CA 94025
Jean-jacques Sunier director BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Societe Generale Asset Management Alternative Investments 10 percent owner 170, PLACE HENRI REGNAULT, LADEFENSE, PARIS I0 92043
Ed Cowle 10 percent owner 6 EAST 45TH ST., SUITE 1000, NEW YORK NY 10017
H Deworth Williams 10 percent owner 2681 EAST PARLEYS WAY, SUITE #204, SALT LAKE CITY UT 84109
Carter Robert P Iii 10 percent owner 25 RADCLIFFE DRIVE, VOORHEES NJ 08043
Harvey N Kaye 10 percent owner 190 NW SPANISH RIVER BLVD., SUITE 101, BOCA RATON FL 33431

BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Headlines

No Headlines